These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15165695)

  • 21. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease.
    Schwab C; Hosokawa M; McGeer PL
    Exp Neurol; 2004 Jul; 188(1):52-64. PubMed ID: 15191802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.
    Siegel GJ; Chauhan NB; Feinstein DL; Li G; Larson EB; Breitner JC; Montine TJ
    Neurology; 2008 Jul; 71(5):383; author reply 383. PubMed ID: 18663190
    [No Abstract]   [Full Text] [Related]  

  • 23. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice.
    Dudal S; Krzywkowski P; Paquette J; Morissette C; Lacombe D; Tremblay P; Gervais F
    Neurobiol Aging; 2004 Aug; 25(7):861-71. PubMed ID: 15212840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decorated plaques in Alzheimer's disease.
    Tabira T
    Ann Neurol; 2009 Jan; 65(1):4-6. PubMed ID: 19194874
    [No Abstract]   [Full Text] [Related]  

  • 25. Lysosome-associated membrane protein 1 (LAMP-1) in Alzheimer's disease.
    Barrachina M; Maes T; Buesa C; Ferrer I
    Neuropathol Appl Neurobiol; 2006 Oct; 32(5):505-16. PubMed ID: 16972884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
    Swerdlow RH
    Neurobiol Aging; 2007 Oct; 28(10):1465-80. PubMed ID: 16876913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer's disease: Moving towards a vaccine.
    Holtzman DM
    Nature; 2008 Jul; 454(7203):418-20. PubMed ID: 18650906
    [No Abstract]   [Full Text] [Related]  

  • 28. Pick bodies in a family with presenilin-1 Alzheimer's disease.
    Halliday GM; Song YJ; Lepar G; Brooks WS; Kwok JB; Kersaitis C; Gregory G; Shepherd CE; Rahimi F; Schofield PR; Kril JJ
    Ann Neurol; 2005 Jan; 57(1):139-43. PubMed ID: 15622541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model.
    Bharathi ; Shamasundar NM; Sathyanarayana Rao TS; Dhanunjaya Naidu M; Ravid R; Rao KS
    Brain Res Rev; 2006 Sep; 52(2):275-92. PubMed ID: 16782202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology.
    Wang YJ; Chen GH; Hu XY; Lu YP; Zhou JN; Liu RY
    Brain Res; 2005 Jan; 1031(1):101-8. PubMed ID: 15621017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. X-34 labeling of abnormal protein aggregates during the progression of Alzheimer's disease.
    Ikonomovic MD; Abrahamson EE; Isanski BA; Debnath ML; Mathis CA; Dekosky ST; Klunk WE
    Methods Enzymol; 2006; 412():123-44. PubMed ID: 17046656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease.
    Simard AR; Soulet D; Gowing G; Julien JP; Rivest S
    Neuron; 2006 Feb; 49(4):489-502. PubMed ID: 16476660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stress proteins in Alzheimer's disease.
    Smith RC; Rosen KM; Pola R; Magrané J
    Int J Hyperthermia; 2005 Aug; 21(5):421-31. PubMed ID: 16048839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The amyloid cascade hypothesis.
    Korczyn AD
    Alzheimers Dement; 2008 May; 4(3):176-8. PubMed ID: 18631966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.
    Buerger K; Ewers M; Pirttilä T; Zinkowski R; Alafuzoff I; Teipel SJ; DeBernardis J; Kerkman D; McCulloch C; Soininen H; Hampel H
    Brain; 2006 Nov; 129(Pt 11):3035-41. PubMed ID: 17012293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inherited neurodegenerative diseases and transgenic models.
    Borchelt DR
    Lab Anim Sci; 1998 Dec; 48(6):604-10. PubMed ID: 10090084
    [No Abstract]   [Full Text] [Related]  

  • 39. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
    Pei JJ; Sjögren M; Winblad B
    Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abeta-globulomers are formed independently of the fibril pathway.
    Gellermann GP; Byrnes H; Striebinger A; Ullrich K; Mueller R; Hillen H; Barghorn S
    Neurobiol Dis; 2008 May; 30(2):212-20. PubMed ID: 18353662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.